Rifax Tablet 550 mg is a broad-spectrum antibiotic used to treat various bacterial infections in the gastrointestinal tract. It is a semi-synthetic derivative of rifamycin and is primarily used for its local action within the gut, minimizing systemic absorption. Rifax Tablet 550 mg is effective against a range of Gram-positive and Gram-negative bacteria.
Rifax Tablet 550 mg is used for:
| Brand Name | Rifax |
|---|---|
| Type | Tablet |
| Weight | 550 mg |
| Generic | Rifaximin |
| Manufacturer | Beacon Pharmaceuticals PLC |
| Available in | English বাংলা |
Rifax Tablet 550 mg works by inhibiting bacterial RNA polymerase, which prevents the transcription of bacterial DNA into RNA. This action disrupts bacterial protein synthesis, leading to the death of susceptible bacteria. Its minimal systemic absorption ensures that it exerts its effects locally within the gastrointestinal tract, reducing the risk of systemic side effects.
For traveler's diarrhea, Rifax Tablet 550 mg typically starts to alleviate symptoms within 24 to 48 hours of initiating therapy. For hepatic encephalopathy, improvements may be observed within 1 to 2 weeks of treatment. For irritable bowel syndrome with diarrhea, it may take several weeks to achieve optimal symptom relief.
Rifax Tablet 550 mg is poorly absorbed from the gastrointestinal tract. Less than 0.4% of the drug is absorbed systemically, which allows it to act primarily within the gut. This low systemic absorption reduces the risk of systemic side effects and interactions.
Rifax Tablet 550 mg is excreted primarily in the feces, with minimal amounts appearing in the urine. The drug is extensively metabolized in the gut and does not significantly enter the systemic circulation, further emphasizing its localized action.
The dosage of Rifax Tablet 550 mg varies depending on the condition being treated:
Rifax Tablet 550 mg is administered orally in tablet form. It should be taken with or without food according to the prescribed dosage. It is important to complete the full course of therapy as directed to ensure effective treatment and reduce the risk of resistance.
Common side effects include:
Rifax Tablet 550 mg toxicity is rare due to its minimal systemic absorption. However, overdose or prolonged use could potentially lead to gastrointestinal disturbances or allergic reactions. In case of suspected overdose, supportive care and symptomatic treatment should be provided.
Precautions include:
Rifax Tablet 550 mg has a low potential for drug interactions due to its minimal systemic absorption. However, it is still important to inform healthcare providers of all other medications being taken, including over-the-counter drugs and supplements, to avoid any potential interactions.
Rifax Tablet 550 mg should be used with caution in:
Rifax Tablet 550 mg has minimal drug interactions due to its limited systemic absorption. However, caution is advised when used with medications that affect gut motility or have similar effects on the gastrointestinal tract. Always consult a healthcare provider before combining Rifax Tablet 550 mg with other drugs.
Rifax Tablet 550 mg can be taken with or without food. There are no specific food interactions known to affect its efficacy. However, maintaining a balanced diet and avoiding excessive alcohol may help reduce gastrointestinal side effects.
Rifax Tablet 550 mg is classified as pregnancy category B. Animal studies have not demonstrated any risk to the fetus, but there are limited human studies. It should be used during pregnancy only if the potential benefits outweigh the risks. Consult a healthcare provider for personalized advice.
Rifax Tablet 550 mg is excreted in very low concentrations in breast milk. It is generally considered safe for use during breastfeeding, but caution is advised. Consult a healthcare provider before using Rifax Tablet 550 mg while breastfeeding to assess the potential risks and benefits.
Acute overdose of Rifax Tablet 550 mg may lead to gastrointestinal symptoms such as severe nausea, vomiting, and abdominal pain. In the event of an overdose, supportive care should be provided, and medical evaluation is recommended to manage symptoms and ensure safety.
Rifax Tablet 550 mg is contraindicated in:
Rifax Tablet 550 mg should be used according to the prescribed dosage and duration. It is important to:
Rifax Tablet 550 mg should be stored at room temperature (15-30°C or 59-86°F), away from light and moisture. Keep the medication tightly closed and out of reach of children. Do not use beyond the expiration date.
The volume of distribution for Rifax Tablet 550 mg is not well-defined due to its minimal systemic absorption. Its therapeutic action is localized primarily to the gastrointestinal tract.
The half-life of Rifax Tablet 550 mg is approximately 6 to 8 hours. The drug's effects are maintained locally within the gut due to its low systemic absorption.
Rifax Tablet 550 mg is primarily cleared through the feces with minimal renal clearance. Its systemic clearance is low, reflecting its primary action within the gastrointestinal tract and minimal absorption into the systemic circulation.
See in details version Rifax Tablet 550 mg also Rifax Tablet 550 mg in bangla
Dr. Mohammad Abdur Rahim
Pain, Arthritis, Paralysis, Physical Medicine & Rehabilitation Specialist
Maj. Gen. Prof. Dr. Md. Abdul Moyeed Siddiqui
Medicine, Liver & Gastroenterology Specialist